News | Radial Access | January 15, 2020

SCAI Updates Expert Consensus Statement on Best Practices for Transradial Access

The Society for Cardiovascular Angiography and Interventions (SCAI) released an updated expert consensus statement for the “SCAI Best Practices for Transradial Angiography and Intervention.”

January 15, 2020 — The Society for Cardiovascular Angiography and Interventions (SCAI) released an updated expert consensus statement for the best practices for transradial artery access used for diagnostic angiography and interventional procedures. [1]

The new document updates the 2013 publication of the “SCAI Best Practices for Transradial Angiography and Intervention,” because the the body of evidence for both the technical aspects of transradial procedures and their application has changed considerably over the past seven years. Notably, several randomized and observational studies have been conducted to address previously unanswered questions described in the initial publication. In response, SCAI convened a panel of experts to summarize the available contemporary data and reach a consensus on how these findings should be translated into clinical practice.

Read the new Best Practices for Transradial Angiography and Intervention document.

Transradial angiography and intervention continues to become increasingly common as an access site for coronary procedures. SCAI said since the first best practices paper in 2013, ongoing trials have shed further light onto the safest and most efficient methods to perform these procedures. Specifically, this document comments on the use of ultrasound to facilitate radial access, the role of ulnar artery access, the utility of non‐invasive testing of collateral flow, strategies to prevent radial artery occlusion, radial access for primary percutaneous coronary intervention (PCI) and topics that require further study.

In less than a decade there has been explosive growth in the use of transradial access in the patient's wrist over the previous standard of care using femoral artery access in the groin. Use of radial access in the United States, radial access use went from about 5 percent of procedures to about 50 percent, based on data from the American College of Cardiology (ACC) National Cardiovascular Data Registry (NCDR) CathPCI Registry. 

Watch the VIDEO: Trends in Radial Access for Percutaneous Coronary Interventions, an interview at TCT 2019 with Sunil Rao, M.D., and Prashant Kaul, M.D.

Watch a VIDEO of the first author Adhir R. Shroff, M.D., explaining the new guidelines at SCAI 2019.

 

Reference:
1. Adhir R. Shroff MD, MPH, FSCAI (Chair)  Rajiv Gulati MD, PhD, FSCAI (Co‐Chair)  Douglas E. Drachman MD, FSCAI  Dmitriy N. Feldman MD, FSCAI  Ian C. Gilchrist MD, FSCAI, et al. SCAI expert consensus statement update on best practices for transradial angiography and intervention. Catheterization and Cardiovascular Interventions. First published: 27 December 2019 https://doi.org/10.1002/ccd.28672
 

Related Content

Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.
Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...
People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.  In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.

News | Cath Lab | January 02, 2020 | Dave Fornell, Editor
January 2, 2020 — In early December 2019, leaders of the European As...
News | Cath Lab | December 18, 2019
December 18, 2019 — Cook Medical initiated a recall of its CrossCath Support Catheters in November, which the U.S.
Gallery | Cath Lab | October 31, 2019 | Dave Fornell, Editor
This is a photo essay of the interventional cardiology and structural heart technologies on the expo floor and discus
The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

Technology | Cath Lab | October 28, 2019
Office based labs (OBLs) and ambulatory surgery centers (ASCs) require a fresh perspective from imaging vendors.
Marco Costa, M.D., Ph.D., MBA, president, UH Harrington Heart and Vascular Institute, performing a cath lab procedure.

Marco Costa, M.D., Ph.D., MBA, president, UH Harrington Heart and Vascular Institute, performing a cath lab procedure.

News | Cath Lab | October 28, 2019
October 28, 2019 — Leaders within University Hospitals and the Harrington Heart and Vascular Institute had a vision t
OmniVision Announces Guinness World Record for Smallest Image Sensor

OmniVision's OVM6948 CameraCubeChip, a fully packaged, wafer-level camera module measuring 0.65mm x 0.65mm x 1.158mm, built on OmniVision's OV6948, winner of the Guinness World Record for “The Smallest Image Sensor Commercially Available.”

News | Cath Lab | October 22, 2019
October 22, 2019 — OmniVision Technologies Inc.
People watch the presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., live in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long term surgical outcomes. #TCT2019

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes. 

Feature | Cath Lab | October 03, 2019
October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with pe
Overlay Init